USANA Health Sciences Files 8-K/A Amendment

TL;DR

USANA filed an amendment to its 8-K, correcting/adding financial info from Dec 23, 2024.

AI Summary

USANA Health Sciences, Inc. filed an 8-K/A on March 7, 2025, to amend its previous filing. The amendment pertains to financial statements and exhibits related to the period ending December 23, 2024. The company, incorporated in Utah, is in the medicinal chemicals and botanical products sector.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors.

Risk Assessment

Risk Level: low — This is a routine amendment to a previous filing, not indicating new negative events.

Key Numbers

• 001-35024 — SEC File Number (Identifies the company's filings with the SEC)
• 87-0500306 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

• USANA HEALTH SCIENCES, INC. (company) — Registrant
• December 23, 2024 (date) — Earliest event reported
• March 7, 2025 (date) — Filing date
• Utah (location) — State of incorporation
• Salt Lake City (location) — Principal executive offices

FAQ

From the Filing

0000896264-25-000082.txt : 20250307 0000896264-25-000082.hdr.sgml : 20250307 20250307152554 ACCESSION NUMBER: 0000896264-25-000082 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 33 CONFORMED PERIOD OF REPORT: 20241223 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250307 DATE AS OF CHANGE: 20250307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 25719705 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 8-K/A 1 usna-20241223.htm 8-K/A usna-20241223 TRUE 0000896264 0000896264 2024-12-23 2024-12-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________ FORM 8-K/A _____________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 23, 2024 USANA HEALTH SCIENCES, INC. (Exact name of registrant as specified in its charter) Utah (State or other jurisdiction of incorporation) 001-35024 87-0500306 (Commission File No.) (IRS Employer Identification No.) 3838 West Parkway Boulevard Salt Lake City , Utah 84120 (Address of principal executive offices, Zip Code) Registrant's telephone number, including area code: ( 801 ) 954-7100 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share USNA New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o EXPLANATORY NOTE This Amendment No. 1 on Form 8-K/A (this “ Amendment ”) is being filed by USANA Health Sciences, Inc. (the “ Company ” or “ USANA ”) with the U.S. Securities and Exchange Commission (the “ SEC ”) for the purpose of amending and supplementing Item 9.01 of that certain Current Report on Form 8-K originally filed by the Company with the SEC on December 23, 2024 (the “ Original Form 8-K ”), in which the Company reported, among other things, USANA’s acquisition of a controlling interest in Hiya Health Products, LLC, a Delaware limited liability company ( “ Hiya ”), pursuant to an Agreement and Plan of Merger dated December 23, 2024 (the “ Merger Agreement ”) by and among USANA, Karate Merger Sub, LLC, a Delaware limited liability company and a wholly-owned